WCPO: UC scientist finds new solution to fight superbug infections
Professor Hassett takes on some of the nastiest infections resistant to antibiotics
Journalist Paulo Suro speaks with Daniel Hassett, PhD, professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology, about his patented treatment AB569 and its possible use to treat cystic fibrosis, chronic obstructive pulmonary disease and other infections. AB569 tackles some of the nastiest superbugs on the planet and currently being tested in human trials to ensure its safety for future patients.
Related Stories
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Breakthrough skin science discovery
March 12, 2026
A research collaboration between the University of Cincinnati and global cosmetics company Kose led to the creation of a novel anti aging spot fading serum.